Introducing 1,3-Beta-D-glucan for screening and diagnosis of invasive fungal diseases in Australian high risk haematology patients: is there a clinical benefit?
Katherine GarnhamCatriona L HallidayNeela Joshi RaiMenuk JayawadenaTasnim HasanJen KokVineet NayyarDavid J GottliebNicole M GilroySharon C-A ChenPublished in: Internal medicine journal (2020)